Found: 5
Select item for more details and to access through your institution.
Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas.
- Published in:
- Cancer & Metabolism, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40170-022-00281-0
- By:
- Publication type:
- Article
Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.
- Published in:
- Pigment Cell & Melanoma Research, 2018, v. 31, n. 1, p. 11, doi. 10.1111/pcmr.12661
- By:
- Publication type:
- Article
Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition.
- Published in:
- Pigment Cell & Melanoma Research, 2012, v. 25, n. 2, p. 248, doi. 10.1111/j.1755-148X.2011.00950.x
- By:
- Publication type:
- Article
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50881-1
- By:
- Publication type:
- Article
Tumour necrosis factor-α depletes histone deacetylase 1 protein through IKK2.
- Published in:
- EMBO Reports, 2006, v. 7, n. 3, p. 291, doi. 10.1038/sj.embor.7400613
- By:
- Publication type:
- Article